FLOLAN (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the FLOLAN drug offered from GlaxoSmithKline LLC. This Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
NON-PROPRIETARY NAME: | epoprostenol sodium |
SUBSTANCE NAME: | EPOPROSTENOL SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1995-12-08 |
END MARKETING DATE: | 0000-00-00 |
FLOLAN HUMAN PRESCRIPTION DRUG Details:
Item Description | FLOLAN from GlaxoSmithKline LLC |
LABELER NAME: | GlaxoSmithKline LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/1) |
START MARKETING DATE: | 1995-12-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0173-0517_b9f0d662-3e2d-4681-944d-cd320ff65321 |
PRODUCT NDC: | 0173-0517 |
APPLICATION NUMBER: | NDA020444 |
Other EPOPROSTENOL SODIUM Pharmaceutical Manufacturers / Labelers: